Advertisement

What is new with inhaled anesthetics: Part 1

  • James R Walker
    Correspondence
    Address correspondence to James R. Walker, MS, CRNA, 6550 Fannin, Suite 1003, Houston, TX 77030.
    Affiliations
    Department of Anesthesiology Graduate Program in Nurse Anesthesia at Baylor College of Medicine, Houston, TX USA.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Inhaled anesthetic agents are widely used in the maintenance of general anesthesia. The newer agents, desflurane and sevoflurane, possess pharmacokinetic profiles that are distinctly different from the older inhaled anesthetics. These differences significantly impact the PACU nursing care. This article will focus on the uptake, distribution, and elimination of inhaled anesthetic agents with emphasis being placed on the postanesthesia care of surgical patients receiving these newer agents.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of PeriAnesthesia Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eger EI
        Anesthetic uptake and action.
        Williams and Wilkins, Baltimore, MD1974
        • Stoelting RK
        Pharmacology and physiology in anesthetic practice.
        ed 2. Lippincott, Philadelphia, PA1991
        • Barash PG
        • Cullen BF
        • Stoelting RK
        Clinical anesthesia.
        ed 2. Lippincott, Philadelphia, PA1992
        • Eger II, EI
        • Larson Jr, CP
        Anaesthetic solubility in blood and tissues: values and significance.
        Brit J Anaesth. 1964; 36: 140-149
        • Yasuda N
        • Targ AG
        • Eger II, EI
        Solubility of I-653, sevoflurane, isoflurane, and halothane in human tissues.
        Anesth Analg. 1989; 69: 370
        • Eger RR
        • Eger II, EI
        Effects of temperature and age on the solubility of enflurane, halothane, isoflurane, and methoxyflurane in human blood.
        Anesth Analg. 1978; 57: 224
        • Eger EI
        Desflurane: A compendium and reference.
        Healthpress Publishing Group, Inc, Rutherford, NJ1993
        • Miller RD
        The clinical pharmacology of sevoflurane.
        Anesth Analg. 1995; 81: S1-S71
        • Hong K
        • Trudell JR
        • O'Neil JR
        • et al.
        Biotransformation of nitrous oxide.
        Anesthesiology. 1980; 53: 354-355
        • Sutton TS
        • Koblin DD
        • Gruenke LD
        • et al.
        Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane.
        Anesth Analg. 1991; 73: 180-185
        • Holaday DA
        • Fiserova-Bergerova V
        • Latto IP
        • et al.
        Resistance of isoflurane to biotransformation in man.
        Anesthesiology. 1975; 43: 325-332
        • Chase RE
        • Holaday DA
        • Fiserova-Bergerova V
        • et al.
        The biotransformation of enflurane in man.
        Anesthesiology. 1971; 35: 262-267
        • Holaday DA
        • Smith FR
        Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers.
        Anesthesiology. 1981; 54: 100-106
        • Rehder K
        • Forbes J
        • Alter H
        • et al.
        Halothane biotransformation in man: a quantitative study.
        Anesthesiology. 1970; 28: 711-715